Reported Sunday, Anteris Reports 30-Day EMBARK Results For Investigational Medium-Size DurAVR THV In 22 Patients: 6.17 mmHg Mean Gradient, 2.64 cm2 EOA, No Moderate Or Severe PVL Or PPM
Share
Why It Matters
Anteris tested a new heart valve on 22 patients with good early results. Watch how many more patients they test and if the results stay this good.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.